International Medical Center or IMC is a large hospital in Jeddah, Saudi Arabia, and was built in 2005. The CEO of the Center is Dr. Walid Fitaihi. The IMC is a multi-disciplinary hospital that features specialty centers providing a wide range of comprehensive treatment options for different health problems.

There are 300 beds in International Medical Center.

During the past decade, International Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Medical Center" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "ClinTrio Ltd." with 1 trials sponsored, "King Fahad Specialist Hospital Dammam" with 1 trials sponsored and "Société Internationale d'Urologie" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Medical Center" #1 collaborator was "John Hopkins Aramco Healthcare" with 1 trials as a collaborator, "King Abdulaziz Medical City" with 1 trials as a collaborator, "King Fahad Medical City" with 1 trials as a collaborator, "King Fahad Military Medical Complex" with 1 trials as a collaborator and "King Fahad University Hospital" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "International Medical Center" are "Breast Cancer" (1 trials), "Convalescent Plasma for COVID 19" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Morbid Obesity Requiring Bariatric Surgery" (1 trials) and "Stone Ureter" (1 trials). Many other conditions were trialed in "International Medical Center" in a lesser frequency.

Most popular intervention types in "International Medical Center" are "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials), "Carboplatin" (1 trials) and "Conventional laparoscopic Roux-en-Y gastric bypass" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Medical Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "International Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in International Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".